{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:31:37Z","timestamp":1772814697715,"version":"3.50.1"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.crohns.2008.02.002","type":"journal-article","created":{"date-parts":[[2008,6,27]],"date-time":"2008-06-27T05:05:57Z","timestamp":1214543157000},"page":"241-245","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy of Infliximab treatment in patients with severe Fistulizing Hidradenitis Suppurativa"],"prefix":"10.1093","volume":"2","author":[{"given":"Margarita","family":"Elkjaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte","family":"Dinesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Benazzato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"L\u00f8gager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Munkholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"issue":"1","key":"10.1016\/j.crohns.2008.02.002_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1396-0296.2004.04007.x","article-title":"Hidradenitis suppurativa: a review","volume":"17","author":"Wiseman","year":"2004","journal-title":"Dermatol Ther"},{"issue":"2 Pt 1","key":"10.1016\/j.crohns.2008.02.002_bib2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.crohns.2008.02.002_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-4362.1983.tb02150.x","article-title":"Topical treatment of hidradenitis suppurativa with clindamycin","volume":"22","author":"Clemmensen","year":"1983","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.crohns.2008.02.002_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.crohns.2008.02.002_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.1986.tb05741.x","article-title":"Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy","volume":"115","author":"Sawers","year":"1986","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.crohns.2008.02.002_bib6","first-page":"289P","article-title":"Cyclosporin-responsive hidradenitis suppurativa","volume":"88","author":"Buckley","year":"1995","journal-title":"J R Soc Med"},{"issue":"1","key":"10.1016\/j.crohns.2008.02.002_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0190-9622(99)70530-X","article-title":"Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa","volume":"40","author":"Boer","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.crohns.2008.02.002_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s003840050159","article-title":"Extent of surgery and recurrence rate of hidradenitis suppurativa","volume":"13","author":"Ritz","year":"1998","journal-title":"Int J Colorectal Dis"},{"issue":"5 Suppl","key":"10.1016\/j.crohns.2008.02.002_bib9","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0190-9622(03)01132-0","article-title":"Infliximab for the treatment of hidradenitis suppurativa","volume":"49","author":"Lebwohl","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.crohns.2008.02.002_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1001\/archderm.139.12.1540","article-title":"Severe hidradenitis suppurativa treated with infliximab infusion","volume":"139","author":"Adams","year":"2003","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.crohns.2008.02.002_bib11","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.crohns.2008.02.002_bib12","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11926-004-0006-3","article-title":"Infliximab in rheumatoid arthritis","volume":"6","author":"Moreland","year":"2004","journal-title":"Curr Rheumatol Rep"},{"issue":"9317","key":"10.1016\/j.crohns.2008.02.002_bib13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.crohns.2008.02.002_bib14","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"10.1016\/j.crohns.2008.02.002_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1440-0960.2004.00090.x","article-title":"Use of infliximab in the treatment of psoriasis","volume":"45","author":"Lee","year":"2004","journal-title":"Australas J Dermatol"},{"issue":"18","key":"10.1016\/j.crohns.2008.02.002_bib16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn's disease","volume":"340","author":"Present","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2008.02.002_bib17","article-title":"Infliximab dependency in children with Crohn's disease","author":"Wever","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994608000275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994608000275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/2\/3\/241\/7799293\/2-3-241.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T21:56:57Z","timestamp":1503439017000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2008.02.002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1873994608000275"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2008.02.002","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}